Immune Pharmaceuticals Inc (fka IMNPQ)

[Bigtrade PT]

Immune Pharmaceuticals Delists from Nasdaq Stockholm Effective March 9, 2018
Englewood Cliffs, NJ (March 8, 2018) - Immune Pharmaceuticals, Inc. (NASDAQ; IMNP) ("Immune" or the "Company") a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, announced today that effective at the close of the market on Friday, 9 March 2018, the Company's common stock will no longer trade on the Nasdaq First North Premier Stockholm ("Nasdaq First North") exchange as a consequence of a previously disclosed decision by the Nasdaq First North Disciplinary Committee. The Committee's decision stated that the delisting would be effected by 29 March 2018 at the latest; however, Nasdaq First North determined that the last day of trading shall be Friday 9 March 2018, as previously disclosed by Nasdaq First North on 9 February 2018.

https://www.bequoted.com/bolag/immune-pharmaceuticals/pressmeddelande/immune-pharmaceuticals-delists-from-nasdaq-stockholm-effecti-64141?page=2